Alexion Pharmaceuticals, Inc. · 9 hours ago
Scientific Writing & Project Management Intern
Alexion Pharmaceuticals, Inc. is seeking an intern for a 12-week internship role focused on CMC (Chemistry, Manufacturing, and Controls) due diligence projects. The intern will support project management activities by integrating AI predictive tools, working cross-functionally with teams, and receiving training in CMC project management.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Integrating AI predictive tools to estimate timelines, resourcing, and budget impacts; and assisting with manufacturing cost-of-goods analyses to inform valuation
Working cross-functionally with Biopharmaceutical Development (BPD) teams to consolidate inputs on headcount, vendor needs, funding requirements, and schedule risk, to produce concise, decision-ready summaries aligned to due diligence reports
Providing the intern with CMC project management training, including resourcing models, critical-path scheduling, and understanding governance decisions from due diligence
Qualification
Required
Junior and Masters-level students majoring in Biochemistry, biology, chemistry, bioengineering, data science, or a related field
Candidates must have an expected graduation date after August 2026
Application development skills and proficiency in programming languages such as Python that can be applied to current company integrated software systems
Data analysis and Programming experience such as conducting multi-variable analysis/modeling, and strong proficiency in ML, AI predictive tools and models required
Visualization Tools such as PowerBI required
Understanding of biological, antibodies, and complex data analysis required
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3-5 days per week. This role will not provide relocation assistance
Preferred
CMC experience
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase